Meeder Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.2K | Sell |
|
|||||
|
2025
Q2 | $10.1K | Buy |
|
|||||
|
2025
Q1 | $7.02K | Sell |
|
|||||
|
2024
Q4 | $8.94K | Buy |
|
|||||
|
2024
Q3 | $10.2K | Sell |
|
|||||
|
2024
Q2 | $78K | Buy |
|
|||||
|
2024
Q1 | $3.59K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $11K | Buy |
|
|||||
|
2022
Q2 | $7K | Sell |
|
|||||
|
2022
Q1 | $10K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $964K | Buy |
|
|||||
|
2021
Q2 | $11K | Sell |
|
|||||
|
2021
Q1 | $10K | Sell |
|
|||||
|
2020
Q4 | $11K | Sell |
|
|||||
|
2020
Q3 | $722K | Sell |
|
|||||
|
2020
Q2 | $816K | Sell |
|
|||||
|
2020
Q1 | $766K | Sell |
|
|||||
|
2019
Q4 | $1.66M | Buy |
|
|||||
|
2019
Q3 | $95K | Sell |
|
|||||
|
2019
Q2 | $97K | Buy |
|
|||||
|
2019
Q1 | $32K | Buy |
|
|||||
|
2018
Q4 | $6K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $24.5K | Sell |
|
|||||
|
2018
Q1 | $97K | Sell |
|
|||||
|
2017
Q4 | $307K | Buy |
|
|||||
|
2017
Q3 | $49K | Buy |
|
|||||
|
2017
Q2 | $7K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $175K | Buy |
|